PMC:7565665 / 1371-1700 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T9","span":{"begin":63,"end":67},"obj":"Body_part"},{"id":"T10","span":{"begin":237,"end":241},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"well as the progression of chronic obstructive and restrictive lung diseases. In addition, the autophagic dysfunction-mediated cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeutic potential of novel autophagy augmen"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T4","span":{"begin":63,"end":67},"obj":"Body_part"},{"id":"T5","span":{"begin":237,"end":241},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"well as the progression of chronic obstructive and restrictive lung diseases. In addition, the autophagic dysfunction-mediated cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeutic potential of novel autophagy augmen"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T24","span":{"begin":63,"end":76},"obj":"Disease"},{"id":"T25","span":{"begin":127,"end":142},"obj":"Disease"},{"id":"T26","span":{"begin":237,"end":249},"obj":"Disease"}],"attributes":[{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"},{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0009061"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005275"}],"text":"well as the progression of chronic obstructive and restrictive lung diseases. In addition, the autophagic dysfunction-mediated cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeutic potential of novel autophagy augmen"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T8","span":{"begin":63,"end":67},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T9","span":{"begin":63,"end":67},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T10","span":{"begin":127,"end":178},"obj":"http://purl.obolibrary.org/obo/PR_000001044"},{"id":"T11","span":{"begin":180,"end":184},"obj":"http://purl.obolibrary.org/obo/PR_000001044"},{"id":"T12","span":{"begin":237,"end":241},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T13","span":{"begin":237,"end":241},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"well as the progression of chronic obstructive and restrictive lung diseases. In addition, the autophagic dysfunction-mediated cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeutic potential of novel autophagy augmen"}

{"project":"LitCovid-PubTator","denotations":[{"id":"26","span":{"begin":127,"end":178},"obj":"Gene"},{"id":"27","span":{"begin":180,"end":184},"obj":"Gene"},{"id":"42","span":{"begin":63,"end":76},"obj":"Disease"},{"id":"43","span":{"begin":237,"end":249},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"tao:has_database_id","subj":"26","obj":"Gene:1080"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"Gene:1080"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"MESH:D008171"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:D008171"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"well as the progression of chronic obstructive and restrictive lung diseases. In addition, the autophagic dysfunction-mediated cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeutic potential of novel autophagy augmen"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":51,"end":76},"obj":"Phenotype"},{"id":"T10","span":{"begin":237,"end":249},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002091"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0002088"}],"text":"well as the progression of chronic obstructive and restrictive lung diseases. In addition, the autophagic dysfunction-mediated cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeutic potential of novel autophagy augmen"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T19","span":{"begin":127,"end":178},"obj":"http://purl.obolibrary.org/obo/GO_0005260"},{"id":"T20","span":{"begin":180,"end":184},"obj":"http://purl.obolibrary.org/obo/GO_0005260"},{"id":"T21","span":{"begin":186,"end":201},"obj":"http://purl.obolibrary.org/obo/GO_0006955"},{"id":"T22","span":{"begin":313,"end":322},"obj":"http://purl.obolibrary.org/obo/GO_0016236"},{"id":"T23","span":{"begin":313,"end":322},"obj":"http://purl.obolibrary.org/obo/GO_0006914"}],"text":"well as the progression of chronic obstructive and restrictive lung diseases. In addition, the autophagic dysfunction-mediated cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeutic potential of novel autophagy augmen"}

{"project":"LitCovid-sentences","denotations":[{"id":"T8","span":{"begin":78,"end":250},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"well as the progression of chronic obstructive and restrictive lung diseases. In addition, the autophagic dysfunction-mediated cystic fibrosis transmembrane conductance regulator (CFTR) immune response impairment further exacerbates the lung disease. Recent studies demonstrate the therapeutic potential of novel autophagy augmen"}